Please login to the form below

Not currently logged in
Email:
Password:

breakthrough

This page shows the latest breakthrough news and features for those working in and with pharma, biotech and healthcare.

ASCO: Bavencio boosts survival post-chemo in bladder cancer

ASCO: Bavencio boosts survival post-chemo in bladder cancer

The FDA awarded breakthrough designation to the drug for first-line maintenance use in April, and the investigators reckon the drug could be a ‘game changer’ in this setting.

Latest news

More from news
Approximately 20 fully matching, plus 616 partially matching documents found.

Latest Intelligence

  • Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy

    Selumetinib was given ‘breakthrough therapy’ status and rapidly green-lit by the FDA last month (April) following a promising National Cancer Institute (NCI) Cancer Therapy Evaluation Program sponsored phase 2 trial.

  • Cortellis Drugs to Watch in 2020 report Cortellis Drugs to Watch in 2020 report

    The 11 drugs identified collectively hold 18 orphan drug designations, four FDA breakthrough therapy designations, two EU PRIME designations and one Japanese SAKIGAKE designation.

  • Alzheimer’s: the search for a cure Alzheimer’s: the search for a cure

    Despite the unconventional route by which Biogen came to that finding, some experts hailed the result as a big breakthrough for a field that has been beset by years of failures. ... While explorations of such combinations are yet to yield a breakthrough,

  • Great expectations: the urgent need for common purpose in Alzheimer’s disease Great expectations: the urgent need for common purpose in Alzheimer’s disease

    We can imagine a world where future AD treatments play a major role in health and care system sustainability, but research investment will fall away and future breakthroughs may never be

  • It started with a miss It started with a miss

    Ultimately, launch excellence is about aligning R&D and commercial activities to ensure patients can benefit from breakthrough medicines as safely and quickly as possible. ... Essentially, a good launch is about getting breakthrough treatments to the

More from intelligence
Approximately 0 fully matching, plus 92 partially matching documents found.

Latest appointments

  • Industry appointments Industry appointments

    Sigilon has already reached certain milestones for its Living Therapeutics product platform, including its Afibromer technology, which represents a new class of breakthrough implantable biomaterials.

  • Weekly comms appointments Weekly comms appointments

    This appointment signifies the start of a serious investment period as we plan for growth around a global client base increasingly involved in developing breakthrough technologies in healthcare.”.

  • Cognite appoints Vee Ragunathan Cognite appoints Vee Ragunathan

    to the success of their breakthrough science brands’”.

  • Cognite strengthens team with two new additions Cognite strengthens team with two new additions

    She has demonstrated real drive and talent across a wide range of disease areas including oncology, MS, diabetes and Alzheimer’s, making her ideally suited to help build successful breakthrough science

  • Rubius Therapeutics adds to its board of directors Rubius Therapeutics adds to its board of directors

    experience to Rubius as they progress development of breakthrough cellular therapies for patients in need.”.

More from appointments
Approximately 0 fully matching, plus 28 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 39 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
HAVAS Just::

HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics